Analytical Method and Stability Study for Oral Suspension of Idebenone in Syrspend
Open Access
- 20 September 2023
- journal article
- research article
- Published by MDPI AG in Separations
- Vol. 10 (9) , 517
Abstract
Idebenone (IDB) (2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinone) is a compound synthesized in the early 1980s. Initially developed for the treatment of cognitive disturbances and Alzheimer’s disease, IDB is now studied for Friedreich’s ataxia, Leber’s hereditary optic neuropathy (LHON), or Duchenne muscular dystrophy. The greatest disadvantage of IDB is its low solubility in water, resulting in low bioavailability. Galenic preparations of IDB in customized doses are common for pediatric patients, which can often prove to be the only option for access to therapy. As an antioxidant, the chemical stability of IDB is an essential guarantee for exerting the desired antioxidant action. Stability studies are essential to know the effect of storage conditions of a galenic product. For the first time, a stability-indicating LC-MS method has been developed to define the stability of IDB suspensions in SyrSpend® Sugar-Free Unflavored (Fagron), a carrier phase formulated for setting up suspensions of active pharmaceutical ingredients (APIs) insoluble or poorly insoluble in water and compatible with it. The proposed method was validated for linearity, accuracy, specificity, robustness, matrix effect and recovery, limit of detection (LOD), limit of quantification (LOQ), and repeatability.Keywords
This publication has 17 references indexed in Scilit:
- Stability-Indicating HPLC Assay for Determination of Idebenone in Pharmaceutical FormsJournal of Analytical Methods in Chemistry, 2015
- Developmental origins of non-communicable disease: Implications for research and public healthEnvironmental Health, 2012
- Development and validation of a stability-indicating HPTLC assay method for idebenoneActa Chromatographica, 2011
- Antioxidant idebenone-loaded nanoparticles based on chitosan and N-carboxymethylchitosanNanomedicine: Nanotechnology, Biology and Medicine, 2010
- Pharmacokinetics and metabolism of idebenone in healthy male subjectsEuropean Journal of Clinical Pharmacology, 2009
- Role of UV Light in Photodamage, Skin Aging, and Skin CancerAmerican Journal of Clinical Dermatology, 2009
- Improved Antioxidant Effect of Idebenone-Loaded Polyethyl-2-Cyanoacrylate Nanocapsules Tested on Human FibroblastsPharmaceutical Research, 2002
- Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinonesJournal of Lipid Research, 1996
- Exploring QSAR: Hydrophobic, Electronic, and Steric Constants C. Hansch, A. Leo, and D. Hoekman. American Chemical Society, Washington, DC. 1995. Xix + 348 pp. 22 × 28.5 cm. Exploring QSAR: Fundamentals and Applications in Chemistry and Biology. C. Hansch and A. Leo. American Chemical Society, Washington, DC. 1995. Xvii + 557 pp. 18.5 × 26 cm. ISBN 0-8412-2993-7 (set). $99.95 (set).Journal of Medicinal Chemistry, 1996
- Quantitative determination of vitamin E and oxidized and reduced coenzyme Q by high-performance liquid chromatography with in-line ultraviolet and electrochemical detectionJournal of Chromatography A, 1987